Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Facioscapulohumeral Muscular Dystrophy.
Current HLA testing recommendations to support HCT.
AFM41a: A Novel PAD2 Inhibitor for Sepsis Treatment-Efficacy and Mechanism.
CD226 identifies effector CD8+ T cells during tuberculosis and costimulates recognition of Mycobacterium tuberculosis-infected macrophages.
"Women Leading in Neurology", selected participant (1 of 12 participants, out of >80 applicants)
See All 21 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
"Women Leading in Neurology", selected participant (1 of 12 participants, out of >80 applicants)
2018 -
2019
"Women Leading in Neurology", selected participant (1 of 12 participants, out of >80 applicants)
Awardee:
Susanne Muehlschlegel MD, MPH